Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group
Authors:
Posted in Papers / Human Studies|Original Research / December 16-31, 2025
J Clin Med. 2025 Dec 12;14(24):8793. doi: 10.3390/jcm14248793.
PMID: 41464695 | DOI: 10.3390/jcm14248793
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.